Are peptides legal? Peptide laws in all 50 states
It depends on the peptide, not only the state. FDA approved peptide drugs are legal in all 50 states with a prescription. Most other peptides sold online are unapproved drugs: selling them for human use violates federal law, and a pharmacy can compound one only when federal 503A rules allow it.
Federal law decides which peptides can be approved or compounded at all. Your state decides who may prescribe them by telehealth, which pharmacies may ship to you, and how its pharmacy board treats compounding. Pick your state below for its statute, board, and sources.
By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified
The federal framework for peptides
Five federal rules decide whether a peptide can lawfully reach a patient. States can be stricter than this floor but not looser.
- FDA approval. An approved peptide drug can be prescribed and dispensed anywhere in the country with a prescription. [23]
- 503A compounding, the bulks list, and Category 2. A state-licensed pharmacy may compound for an individual prescription only from a substance that is part of an approved drug, has a USP or NF monograph, or is on the FDA 503A bulks list. Substances FDA places in Category 2 raised significant safety concerns and are not eligible. [1] [2] [4] [5]
- The Pharmacy Compounding Advisory Committee (PCAC). FDA’s advisory committee reviews nominated substances before FDA adds them to the bulks list by rule. After its July 2026 vote, BPC-157, TB-500, MOTS-c, semax, and epitalon await an FDA final rule; until one is published, pharmacies have no federal basis to compound them from bulk. [1] [7]
- 503B outsourcing facilities. FDA-registered outsourcing facilities can compound without patient-specific prescriptions, but under their own bulks list and current good manufacturing practice. [6]
- “Research use only” sales. A peptide marketed or sold for human use without approval is an unapproved new drug, whatever its label says, and FDA has sent warning letters to online sellers. [11] [12] [13]
Sport is a separate question. The WADA Prohibited List bans unapproved substances and peptide hormones in tested competition whether or not a peptide is legal to prescribe. [24]
Federal summary
Federal law sets the floor for every state: an FDA approved peptide (semaglutide, tirzepatide, tesamorelin, bremelanotide) can be prescribed and dispensed anywhere in the country, and a compounded peptide can only be made by a licensed pharmacy from a substance that is an approved drug component, has a USP or NF monograph, or appears on the FDA 503A bulk drug substances list. Peptides that FDA has placed in 503A Category 2, or that are still under review, are not eligible for pharmacy compounding, and "research use only" peptides sold for human use are unapproved drugs under the Federal Food, Drug, and Cosmetic Act. States can be stricter than this floor but not looser.
FDA peptides: approvals and compounding status
Every peptide in this database carries one FDA status, taken from FDA and Federal Register sources and dated on its page. The FDA peptide regulatory tracker logs each change, from Category 2 decisions to advisory committee votes and final rules.
- 35Regulatory: FDA approved
- 9Regulatory: Under FDA review
- 10Regulatory: Removed from Category 2 (Apr 2026)
- 10Regulatory: Not eligible for compounding
- 17Regulatory: Unscheduled
- 1Regulatory: Regulatory status unknown
Awaiting FDA action: BPC-157, Epitalon, Glutathione, KPV, MOTS-c, NAD+, Semax, TB-500 (thymosin beta-4), VIP (vasoactive intestinal peptide).
Which peptides are FDA approved?
35 peptides in this database are FDA approved drugs. Approval covers the uses on each label; anything else is off label. [23]
- Abaloparatide
- Calcitonin
- Cetrorelix
- Cosyntropin
- Degarelix
- Desmopressin
- Dulaglutide
- Enfuvirtide
- Exenatide
- Ganirelix
- Glucagon
- Gonadorelin
- HCG (human chorionic gonadotropin)
- Insulin
- Lanreotide
- Leuprolide
- Linaclotide
- Liraglutide
- Melanotan I (afamelanotide)
- Octreotide
- Oxytocin
- Pramlintide
- PT-141 (bremelanotide)
- Secretin
- Semaglutide
- Setmelanotide
- SS-31 (elamipretide)
- Teriparatide
- Terlipressin
- Tesamorelin
- Tirzepatide
- Triptorelin
- Vasopressin
- Vosoritide
- Ziconotide
Peptide laws in all 50 states
Of 50 states with a published record, 50 allow telehealth prescribing, 17 clearly allow asynchronous (questionnaire or messaging) prescribing, and 50 limit or bar routine compounded GLP-1s. Badges summarize the record; the state page has the statute and caveats.
| State | Telehealth | Async prescribing | Compounded GLP-1 | Verified |
|---|---|---|---|---|
| Alabama AL | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Alaska AK | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Arizona AZ | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Arkansas AR | Regulatory: Allowed | Regulatory: Not allowed | Regulatory: Limited | |
| California CA | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Colorado CO | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Connecticut CT | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Delaware DE | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Florida FL | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Georgia GA | Regulatory: Allowed | Regulatory: Not allowed | Regulatory: Limited | |
| Hawaii HI | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Idaho ID | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Illinois IL | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Indiana IN | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Iowa IA | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Kansas KS | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Kentucky KY | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Louisiana LA | Regulatory: Allowed | Regulatory: Not allowed | Regulatory: Limited | |
| Maine ME | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Maryland MD | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Massachusetts MA | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Michigan MI | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Minnesota MN | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Mississippi MS | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Missouri MO | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Montana MT | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Nebraska NE | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Nevada NV | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| New Hampshire NH | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| New Jersey NJ | Regulatory: Allowed | Regulatory: Not allowed | Regulatory: Limited | |
| New Mexico NM | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| New York NY | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| North Carolina NC | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| North Dakota ND | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Ohio OH | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Oklahoma OK | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Oregon OR | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Pennsylvania PA | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Rhode Island RI | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| South Carolina SC | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| South Dakota SD | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Tennessee TN | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Texas TX | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Utah UT | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Vermont VT | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Virginia VA | Regulatory: Allowed | Regulatory: Allowed | Regulatory: Limited | |
| Washington WA | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| West Virginia WV | Regulatory: Allowed | Regulatory: Not allowed | Regulatory: Limited | |
| Wisconsin WI | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited | |
| Wyoming WY | Regulatory: Allowed | Regulatory: Unclear | Regulatory: Limited |
“Async unclear” means the state’s telehealth law does not clearly address questionnaire-only prescribing. Rules change; each state page shows the date it was last verified. See also the regulatory tracker and cost index.
For what a prescriber can lawfully write today, and what a legitimate visit includes, read how to get peptides prescribed legally. For what clinics mean by the term, read what peptide therapy is.
Peptide legality FAQ
Are peptides legal?
It depends on the peptide. FDA approved peptide drugs, such as semaglutide, tirzepatide, and tesamorelin, are legal in every state with a prescription. Most other peptides sold online are not approved drugs: selling them for human use violates federal drug law, and a pharmacy can compound one only from a substance that federal 503A rules allow. Of the 82 peptides in this database, 35 are FDA approved. [1] [11] [12] [23]
Are peptides legal in California?
Yes, with limits. A California resident can get FDA approved peptides by prescription from a California-licensed prescriber, including through asynchronous telehealth under Business and Professions Code section 2242. Compounded peptides are harder to get than in most states: the Board of Pharmacy's 2025 compounding rules define an "essentially a copy" product more strictly than federal law, and out-of-state pharmacies shipping sterile injectables need nonresident pharmacy and sterile compounding licenses. Selling unapproved new drugs is barred by Health and Safety Code section 111550. [16] [17] [18] [19]
Are peptides legal in Texas?
Yes, with limits. A Texas resident can get FDA approved peptides from a Texas-licensed prescriber, including by telemedicine under Occupations Code chapter 111, and a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy the Texas State Board of Pharmacy licenses. Out-of-state pharmacies shipping sterile compounded injectables need the Class E-S designation and must meet 22 Texas Administrative Code 291.133. The Texas Food, Drug, and Cosmetic Act bars adulterated or misbranded drugs. [20] [21] [22]
Which peptides are FDA approved?
35 peptides in this database are FDA approved drugs, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), tesamorelin (Egrifta), and bremelanotide (PT-141, Vyleesi). An approval covers only the uses on the drug's label. The full list is on this page, and Drugs@FDA is the official record. [23]
Is BPC-157 legal?
BPC-157 is not an FDA approved drug and is not on the 503A bulks list. FDA removed it from 503A Category 2 in April 2026 and its compounding advisory committee recommended it for the bulks list in July 2026, but that vote is advisory. Until FDA publishes a final rule, a 503A pharmacy has no federal basis to compound it from bulk, and state boards cannot authorize what federal law does not. [1] [4] [7]
Are peptides banned in sports?
Many are. The WADA Prohibited List bans substances with no current approval for human use at all times (section S0), and it bans growth hormone releasing peptides and other peptide hormones (section S2). A prescription does not change a peptide's status in tested sport, so check each peptide page for its WADA status. [24]
Sources
- [1]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [2]21 U.S.C. 353a, Pharmacy compounding (Office of the Law Revision Counsel)
- [3]FDA: Compounding and the FDA, questions and answersFDA
- [4]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [5]Federal Register: List of bulk drug substances that can be used to compound drug products in accordance with section 503A (final rule, February 19, 2019)Federal Register, 2019
- [6]FDA: Information for outsourcing facilities (section 503B)FDA
- [7]FDA: Pharmacy Compounding Advisory CommitteeFDA
- [8]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [9]21 U.S.C. 829, Prescriptions (including subsection (e) on controlled substances dispensed by means of the Internet)
- [10]21 CFR 1300.04, Definitions relating to the dispensing of controlled substances by means of the Internet (practice of telemedicine)